ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850 | +2.8% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,800 | +25.3% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,436 | -16.7% | 89,700 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $1,723 | -99.9% | 89,700 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $1,236,000 | -35.5% | 89,700 | -40.3% | 0.00% | -33.3% |
| Q2 2022 | $1,915,000 | -20.1% | 150,200 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $2,396,000 | -18.5% | 150,200 | +14.2% | 0.01% | -14.3% |
| Q4 2021 | $2,939,000 | -23.4% | 131,500 | +1.7% | 0.01% | -36.4% |
| Q3 2021 | $3,836,000 | -30.5% | 129,300 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $5,521,000 | +137.7% | 129,300 | +138.1% | 0.02% | +100.0% |
| Q1 2021 | $2,323,000 | -10.9% | 54,300 | +14.8% | 0.01% | -20.0% |
| Q4 2020 | $2,607,000 | +55.5% | 47,300 | -35.8% | 0.01% | +42.9% |
| Q3 2020 | $1,677,000 | – | 73,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |